由國(guo)(guo)(guo)(guo)家(jia)(jia)發改委(wei)立項(xiang)，國(guo)(guo)(guo)(guo)家(jia)(jia)中(zhong)醫藥管理局及中(zhong)藥標準化(hua)項(xiang)目專家(jia)(jia)委(wei)員會主導，康美藥業牽頭承擔建設的(de)“三七等20種(zhong)中(zhong)藥飲(yin)片國(guo)(guo)(guo)(guo)家(jia)(jia)標準化(hua)建設項(xiang)目”啟動會在深舉行(xing)。項(xiang)目旨(zhi)在建設三七等20種(zhong)中(zhong)藥材及飲(yin)片生產全(quan)過程可控、質(zhi)量信息可追溯的(de)產品標準和評價(jia)體系，打造領先國(guo)(guo)(guo)(guo)際(ji)的(de)品質(zhi)標準，重塑(su)中(zhong)藥的(de)國(guo)(guo)(guo)(guo)際(ji)形(xing)象(xiang)，推(tui)動“中(zhong)國(guo)(guo)(guo)(guo)中(zhong)藥質(zhi)造”。
“三七(qi)等(deng)20種中(zhong)(zhong)藥(yao)(yao)(yao)飲(yin)片國(guo)家(jia)(jia)標(biao)(biao)準(zhun)化(hua)建設(she)項目(mu)”由國(guo)內中(zhong)(zhong)藥(yao)(yao)(yao)行(xing)(xing)業(ye)(ye)龍(long)頭企(qi)業(ye)(ye)康(kang)美(mei)藥(yao)(yao)(yao)業(ye)(ye)、中(zhong)(zhong)國(guo)食品(pin)藥(yao)(yao)(yao)品(pin)檢(jian)(jian)定研究院、中(zhong)(zhong)國(guo)中(zhong)(zhong)醫科(ke)學院中(zhong)(zhong)藥(yao)(yao)(yao)資源中(zhong)(zhong)心(xin)、北京(jing)大學、北京(jing)中(zhong)(zhong)醫藥(yao)(yao)(yao)大學、暨(ji)南(nan)大學等(deng)行(xing)(xing)業(ye)(ye)最高(gao)水平的(de)科(ke)研院所和(he)企(qi)業(ye)(ye)聯合實(shi)施，并委托第三方權(quan)威檢(jian)(jian)測(ce)中(zhong)(zhong)心(xin)進行(xing)(xing)檢(jian)(jian)測(ce)。康(kang)美(mei)藥(yao)(yao)(yao)業(ye)(ye)憑借在(zai)中(zhong)(zhong)藥(yao)(yao)(yao)飲(yin)片行(xing)(xing)業(ye)(ye)的(de)扎(zha)實(shi)基礎和(he)綜合實(shi)力，牽頭組織申報的(de)“三七(qi)等(deng)20種中(zhong)(zhong)藥(yao)(yao)(yao)飲(yin)片國(guo)家(jia)(jia)標(biao)(biao)準(zhun)化(hua)建設(she)項目(mu)”獲得國(guo)家(jia)(jia)發(fa)改委和(he)國(guo)家(jia)(jia)中(zhong)(zhong)醫藥(yao)(yao)(yao)管理批準(zhun)立項，成為承擔(dan)國(guo)家(jia)(jia)中(zhong)(zhong)藥(yao)(yao)(yao)標(biao)(biao)準(zhun)化(hua)項目(mu)品(pin)種最多的(de)中(zhong)(zhong)藥(yao)(yao)(yao)企(qi)業(ye)(ye)。
“構建(jian)中(zhong)藥(yao)優(you)質(zhi)(zhi)產(chan)品標(biao)準(zhun)的長(chang)效(xiao)機(ji)制，實施中(zhong)藥(yao)優(you)質(zhi)(zhi)產(chan)品信息定期公告機(ji)制，有利于促進中(zhong)藥(yao)產(chan)業種好(hao)(hao)藥(yao)、產(chan)好(hao)(hao)藥(yao)、造好(hao)(hao)藥(yao)，推動優(you)質(zhi)(zhi)優(you)價(jia)。”康美藥(yao)業副(fu)董事長(chang)、常(chang)務副(fu)總經理許冬瑾(jin)說(shuo)。